AADR vs ARKG

Both AADR and ARKG are ETFs. AADR has a lower 5-year return than ARKG (5.49% vs 13.41%). Below is the comparison between AADR and ARKG.

AADR ARKG
Security Type ETF ETF
Segment Equity: Global Ex-U.S. - Total Market Growth Equity: Global Biotech
Family AdvisorShares ARK
Net Assets $41.90M $2.36B
Expense Ratio N/A N/A
Management Style passive (index-based) active
Dividend Yield 0.31% 0.00%
Underlying Index -- --
YTD Return -22.16% -47.10%
1-Year Return -24.30% -64.91%
3-Year Return 0.57% -0.59%
5-Year Return 5.49% 13.41%
10-Year Return 6.65% 0.00%

AADR

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return -22.16%
1-Month Return -12.73%
3-Month Return -16.49%
1-Year Return -24.30%
3-Year Return 0.57%
5-Year Return 5.49%
10-Year Return 6.65%
AADR expense ratio is N/A.

AADR holdings

Top 10 Holdings (45.63% of Total Assets)

Name Symbol % Assets
MercadoLibre Inc MELI.SA 7.21%
NICE Ltd ADR NICE 6.54%
Gold Fields Ltd ADR GFI.JO 5.86%
argenx SE ADR ARGX 5.52%
Anglogold Ashanti Ltd ADR AU.JO 3.64%
TAL Education Group ADR TAL 3.63%
ASML Holding NV ADR ASML 3.59%
ZTO Express (Cayman) Inc ADR ZTO 3.35%
Sibanye Stillwater Ltd ADR SBSW.JO 3.21%
LVMH Moet Hennessy Louis Vuitton SE ADR LVMUY.PA 3.08%

AADR pros

None that we could think of.

AADR cons

None that we could think of.

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

    Or use Finny's Comparison Tool to create a comparison you'd like to see.

    ARKG

    ARKG description

    The Fund seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary.

    ARKG performance & returns

    YTD Return -47.10%
    1-Month Return -3.63%
    3-Month Return -28.69%
    1-Year Return -64.91%
    3-Year Return -0.59%
    5-Year Return 13.41%
    10-Year Return 0.00%
    ARKG expense ratio is N/A.

    ARKG holdings

    Top 10 Holdings (52.77% of Total Assets)

    Name Symbol % Assets
    Invitae Corp NVTA 8.84%
    CRISPR Therapeutics AG CRSP 8.44%
    Pacific Biosciences of California Inc PACB 7.19%
    Arcturus Therapeutics Holdings Inc ARCT 5.75%
    Twist Bioscience Corp TWST 4.61%
    CareDx Inc CDNA 3.89%
    Iovance Biotherapeutics Inc IOVA 3.76%
    Personalis Inc PSNL 3.50%
    Exact Sciences Corp EXAS 3.41%
    Seres Therapeutics Inc MCRB 3.38%

    ARKG pros

    The following are ARKG strengths from our perspective:

    • ARKG 3-year return is 34.54%, which is higher than the 3-year return of the benchmark index (MSCI ACWI NR USD), 8.21%.
    • ARKG 5-year return is 24.54%, which is higher than the 5-year return of the benchmark index (MSCI ACWI NR USD), 10.45%.

    ARKG cons

    The following are ARKG weaknesses from our perspective:

    • ARKG net assets are $886.97 million. This fund is not a popular choice with retail investors.
    • ARKG expense ratio is 0.75%, which is not negligible. Is the fund expensive to you, and does it align to your investment strategy?

    Other relevant ARKG comparisons

    You may also want to check out the following ARKG comparisons that investors often look for on Finny

    Or use Finny's Comparison Tool to create a comparison you'd like to see.
    You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.